» Articles » PMID: 16621649

Role of Interferons in the Control of Lassa Virus Replication in Human Dendritic Cells and Macrophages

Overview
Journal Microbes Infect
Publisher Elsevier
Date 2006 Apr 20
PMID 16621649
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Lassa fever is a hemorrhagic fever caused by Lassa virus (LV), which primarily targets human dendritic cells (DC) and macrophages (MP). Massive numbers of viral particles are released with no effect on the viability, activation or maturation of these cells. LV does not inhibit the activation of cells induced by sCD40L or LPS. We report here the consequences of exogenous activation of LV-infected human DC and MP for viral replication. The activation of cells with lipopolysaccharide or exogenous poly(I-C) and the transfection of cells with poly(I-C) strongly inhibited LV replication, at least partly by inducing type I interferon (IFN) synthesis. In contrast, cell stimulation with sCD40L did not induce type I IFN responses or inhibit LV release. Recombinant type I IFNs strongly inhibited LV replication in both cell types, whereas IFNgamma and IFNlambda did not. The modest type I IFN production observed in LV-infected MP, but not in DC, was involved in controlling LV replication in MP. These results provide an explanation for the slower replication of LV in MP than in DC, and suggest that type I IFNs are crucial in the control of LV.

Citing Articles

Depletion of CD4 and CD8 T Cells Reduces Acute Disease and Is Not Associated with Hearing Loss in ML29-Infected STAT1-/- Mice.

Reyna R, Maruyama J, Mantlo E, Manning J, Taniguchi S, Makishima T Biomedicines. 2022; 10(10).

PMID: 36289695 PMC: 9598517. DOI: 10.3390/biomedicines10102433.


Lassa Virus Countermeasures.

Melnik L Curr Top Microbiol Immunol. 2022; 440:111-145.

PMID: 36253593 DOI: 10.1007/82_2022_261.


Understanding Host-Virus Interactions: Assessment of Innate Immune Responses in Cells after Arenavirus Infection.

Brinkmann N, Hoffmann C, Wurr S, Pallasch E, Hinzmann J, Ostermann E Viruses. 2022; 14(9).

PMID: 36146793 PMC: 9506377. DOI: 10.3390/v14091986.


Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing.

Salam A, Duvignaud A, Jaspard M, Malvy D, Carroll M, Tarning J PLoS Negl Trop Dis. 2022; 16(3):e0010289.

PMID: 35353804 PMC: 9000057. DOI: 10.1371/journal.pntd.0010289.


Infection of Human Endothelial Cells with Lassa Virus Induces Early but Transient Activation and Low Type I IFN Response Compared to the Closely-Related Nonpathogenic Mopeia Virus.

Merabet O, Pietrosemoli N, Perthame E, Armengaud J, Gaillard J, Borges-Cardoso V Viruses. 2022; 14(3).

PMID: 35337059 PMC: 8953476. DOI: 10.3390/v14030652.